Standard
Optimal Duration of Anticoagulant Thromboprophylaxis in Total Hip Arthroplasty - New Evidence in 55,540 Patients with Osteoarthritis from the Nordic Arthroplasty Register Association (NARA) Group. / Pedersen, Alma; Andersen, Ina Trolle; Overgaard, Soren; Fenstad, Anne Marie; Lie, Stein Atle; Gjertsen, Jan-Erik; Furnes, Ove.
In:
Pharmacoepidemiology and Drug Safety, Vol. 28, No. 2, SI, 01.08.2019, p. 58.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Pedersen, A, Andersen, IT
, Overgaard, S, Fenstad, AM, Lie, SA, Gjertsen, J-E & Furnes, O 2019, '
Optimal Duration of Anticoagulant Thromboprophylaxis in Total Hip Arthroplasty - New Evidence in 55,540 Patients with Osteoarthritis from the Nordic Arthroplasty Register Association (NARA) Group',
Pharmacoepidemiology and Drug Safety, vol. 28, no. 2, SI, pp. 58. <
https://doi.org/10.1002/pds.4864>
APA
Pedersen, A., Andersen, I. T.
, Overgaard, S., Fenstad, A. M., Lie, S. A., Gjertsen, J-E., & Furnes, O. (2019).
Optimal Duration of Anticoagulant Thromboprophylaxis in Total Hip Arthroplasty - New Evidence in 55,540 Patients with Osteoarthritis from the Nordic Arthroplasty Register Association (NARA) Group.
Pharmacoepidemiology and Drug Safety,
28(2, SI), 58.
https://doi.org/10.1002/pds.4864Vancouver
Pedersen A, Andersen IT, Overgaard S, Fenstad AM, Lie SA, Gjertsen J-E et al. Optimal Duration of Anticoagulant Thromboprophylaxis in Total Hip Arthroplasty - New Evidence in 55,540 Patients with Osteoarthritis from the Nordic Arthroplasty Register Association (NARA) Group. Pharmacoepidemiology and Drug Safety. 2019 Aug 1;28(2, SI):58.
Author
Pedersen, Alma ; Andersen, Ina Trolle ; Overgaard, Soren ; Fenstad, Anne Marie ; Lie, Stein Atle ; Gjertsen, Jan-Erik ; Furnes, Ove. / Optimal Duration of Anticoagulant Thromboprophylaxis in Total Hip Arthroplasty - New Evidence in 55,540 Patients with Osteoarthritis from the Nordic Arthroplasty Register Association (NARA) Group. In: Pharmacoepidemiology and Drug Safety. 2019 ; Vol. 28, No. 2, SI. pp. 58.
Bibtex
@article{0c03927b285a44f9b3b49f1e9f7b9f87,
title = "Optimal Duration of Anticoagulant Thromboprophylaxis in Total Hip Arthroplasty - New Evidence in 55,540 Patients with Osteoarthritis from the Nordic Arthroplasty Register Association (NARA) Group",
author = "Alma Pedersen and Andersen, {Ina Trolle} and Soren Overgaard and Fenstad, {Anne Marie} and Lie, {Stein Atle} and Jan-Erik Gjertsen and Ove Furnes",
year = "2019",
month = aug,
day = "1",
language = "English",
volume = "28",
pages = "58",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "JohnWiley & Sons Ltd",
number = "2, SI",
note = "35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management : Using Real World Data and Designs to Optimize Decisions, ICPE 2019 ; Conference date: 26-08-2019 Through 28-08-2019",
url = "https://www.pharmacoepi.org/meetings/35icpe/",
}
RIS
TY - ABST
T1 - Optimal Duration of Anticoagulant Thromboprophylaxis in Total Hip Arthroplasty - New Evidence in 55,540 Patients with Osteoarthritis from the Nordic Arthroplasty Register Association (NARA) Group
AU - Pedersen, Alma
AU - Andersen, Ina Trolle
AU - Overgaard, Soren
AU - Fenstad, Anne Marie
AU - Lie, Stein Atle
AU - Gjertsen, Jan-Erik
AU - Furnes, Ove
PY - 2019/8/1
Y1 - 2019/8/1
M3 - Conference abstract in journal
VL - 28
SP - 58
JO - Pharmacoepidemiology and Drug Safety
JF - Pharmacoepidemiology and Drug Safety
SN - 1053-8569
IS - 2, SI
T2 - 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Y2 - 26 August 2019 through 28 August 2019
ER -
